This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Carrboro, NC (US) (2008)
- Durham, NC (US) (2008 - 2010)
Company Filing History:
Years Active: 2008-2010
Title: Douglas McCord Sammond: Innovator in Pharmaceutical Chemistry
Introduction
Douglas McCord Sammond is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on developing innovative compounds that serve as pharmaceutical agents.
Latest Patents
Among his latest patents, Sammond has developed 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors. This invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing these compounds, as well as processes for their preparation and use as pharmaceutical agents. Additionally, he has worked on pyrimidine compounds, which are useful as TIE-2 and/or VEGFR-2 inhibitors. The described invention includes methods of making such pyrimidine derivatives and their application in treating hyperproliferative diseases.
Career Highlights
Sammond has had a distinguished career, working with prominent companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has allowed him to contribute to various innovative projects in the pharmaceutical industry.
Collaborations
Throughout his career, Sammond has collaborated with talented individuals, including Mui Cheung and Holly Kathleen Emerson. These collaborations have further enriched his work and contributed to the success of his inventions.
Conclusion
Douglas McCord Sammond is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile